Rush Cancer Institute Chicago, IL - 60612

Rush Cancer Institute is categorized under Neurologists in Chicago, IL and active since 2002.

Rush Cancer Institute was established in 2002, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Neurologists business, which does work in the B2C market, and is classified as a Neurologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Morie Schumer, Office Manager at the company’s single location by writing to 1725 West Harrison St # 855, Chicago, Illinois IL 60612 or by phoning (312) 942-5000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Rush Cancer Institute
Contact Person: Morie Schumer, Office Manager
Address: 1725 West Harrison St # 855, Chicago, Illinois 60612
Phone Number: (312) 942-5000
Website Address: rush.edu
Annual Revenue (USD): $10.000.000 to $19.9999.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Neurologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Rush Cancer Institute was started in 2002 to provide professional Neurologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact Morie Schumer, Office Manager for inquiries that concern Rush Cancer Institute by calling the company number (312) 942-5000, as your correspondence is most welcome. Additionally, the physical location of the single location of Rush Cancer Institute can be found at the coordinates 41.879336,-87.68647 as well as the street address 1725 West Harrison St # 855 in Chicago, Illinois 60612.

For its online presence, you may visit Rush Cancer Institute’s website at rush.edu and engage with its social media outlets through on Twitter and on Facebook.